Here's Why Adverum Biotechnologies Got Crushed Today [The Motley Fool]
Adverum Biotechnologies, Inc. (ADVM)
Last adverum biotechnologies, inc. earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adverum.gcs-web.com/investor-overview
Company Research
Source: The Motley Fool
The small biopharma announced the departure of both its CEO and CMO. Maxx Chatsko ( TMFBlacknGold ) May 4, 2018 at 12:11PM What happened Shares of gene therapy biopharma Adverum Biotechnologies ( NASDAQ:ADVM ) fell almost 16% today after the company announced that CEO Amber Salzman and Dr. Athena Countouriotis, the CMO, will be leaving the company. The company characterized the CEO's departure as a mutual decision, motivated by the board's desire to have a CEO based out of headquarters in the San Francisco Bay Area. Dr. Salzman had been cross-country commuting from Philadelphia for the last two years, dating back to the merger of her former company, Annapurna Therapeutics, with Avalanche Biotechnologies, which formed Adverum. It appears Dr. Countouriotis resigned her role as CMO as a result of the shake-up at the top. She played a crucial role
Show less
Read more
Impact Snapshot
Event Time:
ADVM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADVM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADVM alerts
High impacting Adverum Biotechnologies, Inc. news events
Weekly update
A roundup of the hottest topics
ADVM
News
- Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting [Yahoo! Finance]Yahoo! Finance
- Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific MeetingGlobeNewswire
- Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year? [Yahoo! Finance]Yahoo! Finance
ADVM
Earnings
- 11/9/23 - Miss
ADVM
Sec Filings
- 4/1/24 - Form EFFECT
- 3/27/24 - Form EFFECT
- 3/21/24 - Form S-3
- ADVM's page on the SEC website